Clinical Trial Update: IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating gefitinib (IRESSA) with radiotherapy and gemcitabine as first-line treatment for locally advanced pancreatic cancer; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED